Valion Bio, Inc. Inventory, Raw Materials, Gross
Valion Bio, Inc. (VBIO) had Inventory, Raw Materials, Gross of $458.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Inventory, Gross
us-gaap:InventoryRawMaterials · last filed 2026-03-30
- 2025-12-31: Inventory, Raw Materials, Gross $458.00K.
- 2025-09-30: Inventory, Raw Materials, Gross $458.00K.
- 2025-06-30: Inventory, Raw Materials, Gross $460.00K.
- 2025-03-31: Inventory, Raw Materials, Gross $461.00K.
| Period end | Inventory, Raw Materials, Gross |
|---|---|
| 2025-12-31 | $458.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $458.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $460.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $461.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $460.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $481.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $526.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $618.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $752.00K 10-K · filed 2025-03-21 |
| 2023-09-30 | $819.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $853.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $817.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $724.00K 10-K · filed 2024-03-25 |
| 2022-09-30 | $645.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $642.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $401.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $281.00K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |